aripiprazole has been researched along with raclopride in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, PS; Schetz, JA; Sibley, DR | 1 |
| Schetz, JA; Sibley, DR | 1 |
| Biziere, K; Bramer, S; Dannals, RF; Dogan, AS; Gründer, G; Ravert, H; Stephane, M; Suri, A; Wong, DF; Yokoi, F | 1 |
| Burris, KD; Kikuchi, T; Miwa, T; Mori, T; Stark, A; Tadori, Y; Tottori, K | 1 |
| Chen, R; Johnson, JL; Jordan, S; Kambayashi, J; Kikuchi, T; Kitagawa, H; McQuade, R; Regardie, K; Tadori, Y | 1 |
| Graff, A; Kapur, S; Mamo, D; Mizrahi, R; Romeyer, F; Shammi, CM | 1 |
| Arakawa, R; Fujiwara, H; Ito, H; Kato, M; Kimura, Y; Kodaka, F; Mimura, M; Nagashima, T; Nogami, T; Sasaki, T; Shimada, H; Suhara, T; Suzuki, M; Takahata, K; Takano, H | 1 |
| Arakawa, R; Ito, H; Kodaka, F; Nogami, T; Suhara, T; Suzuki, M; Takahashi, H; Takahata, K; Takano, H | 1 |
| Howes, OD; Jang, IJ; Jeong, JM; Kapur, S; Kim, BH; Kim, E; Kim, JW; Kwon, JS; Lee, JS; Shin, SG; Turkheimer, FE | 1 |
| Howes, OD; Kim, E; Kim, S; Kwon, JS; Lee, JS; Seo, S; Shin, S | 1 |
| Kim, E; Kim, S; Kwon, JS; Ock, EY | 1 |
3 trial(s) available for aripiprazole and raclopride
| Article | Year |
|---|---|
Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia; Basal Ganglia Diseases; Carbon Radioisotopes; Caudate Nucleus; Cerebral Cortex; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Piperazines; Positron-Emission Tomography; Psychotic Disorders; Putamen; Pyridines; Pyrimidinones; Quinolones; Raclopride; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Treatment Outcome | 2007 |
Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain; Carbon Radioisotopes; Corpus Striatum; Humans; Male; Piperazines; Positron-Emission Tomography; Pyrrolidines; Quinolones; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Salicylamides; Young Adult | 2012 |
The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Carbon Radioisotopes; Cognition; Corpus Striatum; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Memory, Short-Term; Piperazines; Positron-Emission Tomography; Quinolones; Raclopride; Reaction Time; Receptors, Dopamine D2; Single-Blind Method; Young Adult | 2013 |
8 other study(ies) available for aripiprazole and raclopride
| Article | Year |
|---|---|
Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.
Topics: Animals; Binding Sites; COS Cells; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ligands; Membrane Proteins; Mutagenesis, Site-Directed; Protein Conformation; Pyridines; Pyrroles; Rats; Receptors, Dopamine D2; Receptors, Dopamine D4; Structure-Activity Relationship; Transfection | 2000 |
Tandem sulfur-containing amino acids are epicritical determinants of dopamine D(2) receptor pharmacology.
Topics: Amino Acids, Sulfur; Animals; Aripiprazole; Aspartic Acid; Chlorocebus aethiops; COS Cells; Dopamine; Kinetics; Ligands; Piperazines; Point Mutation; Quinolones; Raclopride; Receptors, Dopamine D2 | 2000 |
Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Brain; Cerebellum; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Neurons; Piperazines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Tomography, Emission-Computed | 2002 |
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Lisuride; Piperazines; Piperidines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Risperidone; Transfection; Tritium | 2005 |
In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Calcium Signaling; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Immunoblotting; Lisuride; MAP Kinase Signaling System; Microscopy, Confocal; Mitogen-Activated Protein Kinase 1; Phosphorylation; Piperazines; Piperidines; Quinolones; Raclopride; Receptors, Dopamine D2; Schizophrenia; Time Factors; Transfection | 2007 |
Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Carbon Radioisotopes; Caudate Nucleus; Dopamine; Dopamine D2 Receptor Antagonists; Humans; Levodopa; Male; Neuroimaging; Piperazines; Positron-Emission Tomography; Putamen; Quinolones; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Tissue Distribution; Young Adult | 2012 |
The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [
Topics: Adult; Aripiprazole; Cognition; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Memory, Short-Term; Positron-Emission Tomography; Prospective Studies; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Schizophrenic Psychology | 2018 |
Relationship between subjective well-being and aripiprazole: an [
Topics: Antipsychotic Agents; Aripiprazole; Humans; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2 | 2022 |